Physician profile
Gregory Groglio
NPI 1699791772
$8,108.35
in general payments reported to CMS, 2019-2025
26 companies · $1,648 in 2025
The $1,648 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $544 · 2020: $276 · 2021: $224 · 2022: $795 · 2023: $1,107 · 2024: $3,515 · 2025: $1,648.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,402 · Travel and Lodging: $868.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,401.68 |
| Travel and Lodging | $867.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $4,452.34 | 2022-2025 | Impella |
| Endologix LLC | $1,624.94 | 2019-2025 | Torus Stent Graft System, Endocross Device, Alto Abdominal Stent Graft System |
| Lsi Solutions INC | $370.20 | 2022-2025 | Cor Knot, Cor-Knot |
| Bard Access Systems, INC. | $284.26 | 2019 | |
| Lemaitre Vascular, INC. | $251.75 | 2021-2025 | Artegraft Vascular Graft |
| W. L. Gore & Associates, INC. | $212.84 | 2019-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Tag Conformable Thoracic Endoprosthesis |
| Boston Scientific Corporation | $151.13 | 2025 | Lux-Dx Insertable Cardiac Monitor, Accolade Sr, Emblem Mri S-Icd |
| Bard Peripheral Vascular, INC. | $134.97 | 2020-2021 | |
| Covidien LP | $96.36 | 2019-2020 | |
| Getinge USA Sales, LLC | $89.82 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $64.42 | 2024 | |
| Atricure, INC. | $63.73 | 2024 | |
| Cvrx, INC. | $36.12 | 2024 | Barostim Neo System |
| Medtronic, INC. | $36.07 | 2024 | Penditure |
| Janssen Pharmaceuticals, INC | $33.25 | 2021-2024 | Xarelto |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $28.26 | 2025 | |
| Artivion, INC. | $27.74 | 2019 | |
| Ethicon US, LLC | $20.00 | 2023 | Dermabond Prineo, Stratafix |
| Irhythm Technologies, INC. | $18.29 | 2024 | Zio Xt Patch, Zio Monitor |
| Teleflex LLC | $17.65 | 2023 | Manta |
| Alon Medical Technology | $17.41 | 2025 | |
| Inspire Medical Systems, INC. | $16.50 | 2025 | Inspire |
| Solventum Corporation | $16.37 | 2024 | Prevena |
| Amgen INC. | $15.42 | 2024 | Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $14.99 | 2024 | |
| Glaxosmithkline, LLC. | $13.52 | 2025 | Arexvy, Shingrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Groglio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.